TRANSKRIPT 🔗
WEBVTT
00:00:06.080 --> 00:00:22.640
Beyond the scalpel, where a surgeon's journey outside the operating room explores healthcare, wellness, and human performance through conversations with leaders shaping the future of medicine, mobility, and patient care.
00:00:22.879 --> 00:00:23.839
Welcome, Dr.
00:00:24.079 --> 00:00:25.679
Mamun Al-Rashid.
00:00:31.359 --> 00:00:52.479
Welcome, today's conversation is especially for the engineers, the product managers, and the sales professions in MedTech who want to understand how a device actually goes from concept to the operating room and what it takes to build a career at that intersection.
00:00:52.640 --> 00:00:53.840
My guest today is Mr.
00:00:53.920 --> 00:01:03.039
Ridd Mitra, who is the global vice president of Hip Arthroplasty and the entire hip portfolio at Smith Nephew.
00:01:03.280 --> 00:01:03.439
Mr.
00:01:03.520 --> 00:01:19.599
Mitra trained in computational design and manufacturing at Carnegie Mellon and went on to become one of the architects behind Smith and Nephew's Cory Surgical System, a handheld robotics platform now used in hip and knee replacements around the world.
00:01:19.760 --> 00:01:26.879
He's held leadership roles across product management, RD, and now global marketing for hips and Smith and Nephew.
00:01:27.040 --> 00:01:30.560
And he's a named inventor on multiple surgical robot patents.
00:01:30.719 --> 00:01:36.719
If you work in biomedical engineering, medical device sales, or orthopedic manufacturing, you want to hear from Mr.
00:01:36.799 --> 00:01:37.840
Rodit Mitra.
00:01:38.000 --> 00:01:40.480
Redit, welcome on Beyond the Scalpel.
00:01:40.799 --> 00:01:41.439
Thank you so much, Dr.
00:01:41.519 --> 00:01:42.239
Al-Rashit.
00:01:42.319 --> 00:01:50.480
It is a pleasure being here and to uh speak with you um for uh the the history and the future of robotics in Arthroplasti.
00:01:50.879 --> 00:01:51.680
Thank you, Redit.
00:01:52.400 --> 00:01:55.359
Let's start uh from your early career, Redit.
00:01:55.519 --> 00:02:02.159
And we or we can start from you know, you took a path in studying competit computational design and manufacturing.
00:02:02.319 --> 00:02:06.719
Uh and how did that transition into a medtech look like for you?
00:02:07.040 --> 00:02:08.240
Yeah, that's a great question, Dr.
00:02:08.400 --> 00:02:09.120
Al-Rashid.
00:02:09.280 --> 00:02:12.240
So, my background, I did my master's from Carnegie Mellon.
00:02:12.319 --> 00:02:17.039
I landed in Pittsburgh after having my early uh, you know, education in India.
00:02:17.199 --> 00:02:24.479
My bachelor's was in mechatronics, so I was always fascinated with robotics, electrical technology, and mechanical devices.
00:02:24.719 --> 00:02:30.560
Coming to Pittsburgh, Pittsburgh is an epicenter, it's a hotbed of technology and medicine that comes together.
00:02:30.639 --> 00:02:38.560
And at Carnegie Mellon, I had the opportunity of taking on projects that intersected technology and medtech um altogether.
00:02:38.800 --> 00:02:47.680
At that point in time, there was a startup called Bluebelt Technologies in Pittsburgh who was working on creating a unique, novel, handheld robotic device.
00:02:47.840 --> 00:03:03.759
The genesis of even artificial intelligence and computational design helped our thought process of, you know, when we think about human interactions and human um elements of surgery, how can we bring technology that can enhance and amplify the skills of surgeons?
00:03:03.919 --> 00:03:21.599
So that became my foundational uh journey of thinking about, you know, what additional technologies can we bring into an operating space, into an operating theater that can take, you know, uh centuries old of practice and evolution in orthopedics and bring it to the next level.
00:03:21.759 --> 00:03:33.120
So that's how I began my career and journey of thinking about, you know, building tools, building devices, building robots and uh software that can help in the orthopedic space.
00:03:33.439 --> 00:03:33.840
Wonderful.
00:03:34.159 --> 00:03:53.840
Riddit, was there a moment that you realized that just being extremely having a high aptitude in technology or the technical side in itself is not alone, in itself is not enough that you may need to still understand the commercial and the clinical side of the business to actually uh be engaged in true product development?
00:03:54.159 --> 00:03:55.520
Yeah, it's a great question, Dr.
00:03:55.599 --> 00:03:56.479
Al-Rashid.
00:03:56.560 --> 00:04:04.879
You know, my journey began with uh a very core um engineering backing of what we are designing and developing.
00:04:05.039 --> 00:04:11.199
Um, because there is always a concept as we start our journey in engineering that we are trying to solve a problem.
00:04:11.360 --> 00:04:23.519
And we kind of always define that problem from the viewpoints and the lenses that we have, you know, as we are trying to, you know, code a software or build a robot from that perspective.
00:04:23.680 --> 00:04:30.720
I had very interesting learnings in my early stages with my counterparts in Bluebelt, where we would develop a system, design a system.
00:04:30.959 --> 00:04:38.160
And being a startup, you know, one of the uh luxuries I had was to learn how to build something fast, fail fast.
00:04:38.399 --> 00:04:44.959
And the failures were what defined, you know, how the evolution needs to continue happening in what we are building.
00:04:45.120 --> 00:04:46.399
Is it serving a purpose?
00:04:46.560 --> 00:04:53.680
Is it creating something that actually adds value to a clinician's practice, to a user's practice from that, from that standpoint?
00:04:53.920 --> 00:04:58.639
So that was one of the one of the transformations that I saw, which took the evolutions that we did.
00:04:58.959 --> 00:05:08.000
Because um when I was uh transitioning from Bluebelt to Smith and Nephew, and you know, we we got acquired by Smith and Nephew back in 2016.
00:05:08.160
Load full transcript
--> 00:05:15.519
So it came with you know a lot more resources for us to like innovate and build new uh products and solutions.
00:05:15.839 --> 00:05:21.600
But what you would see is that we did not stop at one point and say, this system is now perfect.
00:05:21.759 --> 00:05:33.600
We started with a pretty big robotic system, but we took a very drastic decision of actually making it smaller, where back then robots were all about you need something big, you need something with an arm.
00:05:33.920 --> 00:05:43.439
But we took that decision of saying, we want to solve something where the surgeon is ultimately the artist who is personalizing surgery for the patient.
00:05:43.600 --> 00:05:53.439
And to do that, we wanted to build tools that augment that surgeon's capabilities and amplifies their skills, their knowledge, their art to a higher standard.
00:05:53.680 --> 00:06:05.120
And that's where we went into the direction of building tools and robotics that can um help the surgeon be faster, be more personalized to the surgery for that patient.
00:06:05.279 --> 00:06:07.040
And that journey always continues.
00:06:07.279 --> 00:06:12.560
And the next part of the question that you asked, which is how does it tie in with the commercial aspects of things?
00:06:12.720 --> 00:06:31.279
You know, at the end of the day, what we build, once it starts coming into real life practice and surgeons actually start using it, it becomes um it has to be economically scalable and it also has to be economically uh profitable for the business as well as for the surgeons and the users who use it.
00:06:31.439 --> 00:06:38.800
And that is also a very um interesting art, I would say, you know, especially for new innovations that come into the market space.
00:06:38.959 --> 00:06:44.240
Because you have economics of scale where new innovations are always you start with 10 systems.
00:06:44.399 --> 00:06:55.920
And when you take you know three years, four years to build that system, how do you take that journey of A, scaling it in market and B, making it something that adds value into the world?
00:06:56.160 --> 00:07:01.680
So these were you know really, really interesting um learnings I had over my uh span of the career.
00:07:01.839 --> 00:07:09.279
And another piece that was very um, you know, I'm I'm I'm fortunate to have had the experience of is scaling in many different markets.
00:07:09.519 --> 00:07:39.920
And as you scale orthopedics and technologies in orthopedics in different markets, you learn the nuances of how US operates versus how Europe operates, all um bound by very, you know, uh different regulatory um challenges or regulatory uh constraints, as well as bound by different uh health economic patterns as to how reimbursement works, or how will a patient pay for a surgery, or how surgeons are incentivized to perform surgery, how many surgeries can they perform?
00:07:40.079 --> 00:07:41.920
Um, in what center are they operating?
00:07:42.079 --> 00:07:42.879
Is it a hospital?
00:07:43.040 --> 00:07:44.160
Is it an ASC?
00:07:44.319 --> 00:07:45.680
Is it a private practice?
00:07:45.839 --> 00:07:52.079
And that changes the microdynamics of how you introduce technologies into uh the space.
00:07:52.240 --> 00:07:55.279
And you can expand this beyond technologies to any product.
00:07:55.519 --> 00:08:19.759
Any product that you build needs to have a clear value that you're delivering to the end user, needs to have a clear value for the ecosystem in which they operate, and ultimately the patient, how will they benefit from this technology or the product that you build that can ultimately transform the status quo of today into something that becomes um more optimized for tomorrow?
00:08:20.160 --> 00:08:21.199
Amazing, amazing.
00:08:21.439 --> 00:08:34.320
And Ruidha, for for a young engineer who was who is starting out, I mean, you mentioned, you know, that you settled in Pittsburgh and you know the the the importance of having a certain ecosystem, right?
00:08:34.480 --> 00:08:39.039
You you want the universities, the manufacturing base, the talent density.
00:08:39.279 --> 00:08:50.799
How what is the importance of that and how would you how did you feel that this was the right ecosystem to really mature and develop your and hone your skills and bring in these innovative uh product designs?
00:08:51.120 --> 00:08:52.879
Yeah, I think that's a that's a great question.
00:08:53.200 --> 00:09:04.720
I think um one piece coming to Carnegie Mellon and coming to Pittsburgh was just the close connections that you can build, you know, around beyond, you know, just the engineering aspects of things.
00:09:04.879 --> 00:09:21.120
I had the opportunity with my uh mentor as well as my professor at that point in time to go to UPMC Children's Hospital or to go to uh you know AGH and meet surgeons and hear of their real world problems that they face beyond their day-to-days of what they do.
00:09:21.279 --> 00:09:29.600
And it creates that connection which at least sparks that question in your mind that, you know, beyond their practice, what other problems can you solve for?
00:09:29.759 --> 00:09:35.360
And having that proximity, having that proximity of, you know, what's the purpose that I want to serve for?
00:09:35.440 --> 00:09:42.879
What are the challenges that I want to address in the world, you know, it really creates an emotional connection to your purpose, to my purpose at least, you know.
00:09:42.960 --> 00:09:49.519
It it created that connection for me to say, you know, this is a space that I really believe that I can make a transformative difference.
00:09:49.759 --> 00:09:57.679
Because once that purpose becomes more deepened, you know, in your ethos, I think it it um becomes more than work.
00:09:57.759 --> 00:10:04.799
You know, it becomes a passion that you can so let's let's move on to you know some of your pioneering work.
00:10:04.879 --> 00:10:15.120
And I think it's fair to
say, you know, you were behind the scenes a a most influential architect in Smith and Nephew's robotic platform, which we know now as Corey.
00:10:15.360 --> 00:10:24.960
And and and uh the reason I say that is you uh as you mentioned, had design ideas along with your team to look at handheld and portable.
00:10:25.519 --> 00:10:27.759
Yeah, I think that's a great question, uh Dr.
00:10:27.919 --> 00:10:28.799
Al-Rashid.
00:10:29.039 --> 00:10:42.799
When you think about design decisions, it it all starts with, you know, uh, like I was mentioning, truly understanding the purpose that we are solving for and what is the ultimate user need from that perspective.
00:10:43.039 --> 00:10:52.240
When we try to create in this world any engineering solution, when we think about mobile phones, every phone used to have a keypad on top of it.
00:10:52.399 --> 00:11:02.480
And the innovation that kept happening is how do I make the phones become smaller so that I can carry it in my pocket, I can you know have it be mobile in nature.
00:11:02.639 --> 00:11:05.200
But it was all incremental from that perspective.
00:11:05.360 --> 00:11:32.080
When we think about the world of robotics and orthopedics, the problem that we are solving for is essentially making sure that the surgeons have the confidence, because every surgeon you know goes through their practice, fellowship, residency, creates their brand, their position in their market space to say, you know, here's why you come to me and here's why you know my hands and my surgical techniques will help you patient work better.
00:11:32.320 --> 00:11:46.399
But in this world, we do see that while orthopaedic surgery has, you know, really transformed over the last, you know, 20 years, 30 years, the surgeries have become safer, they've become better, you know, failure rates have gone down.
00:11:46.639 --> 00:11:52.320
But there is an element of patient satisfaction that still stays a little variable from patient to patient.
00:11:52.480 --> 00:11:59.039
There are those times where the surgeon looks at the you know, a knee or a hip and says, I've done a great job, the x-ray looks great.
00:11:59.120 --> 00:12:02.559
And the patient comes back and says, Yeah, but it doesn't quite feel right, you know.
00:12:02.879 --> 00:12:25.039
And the problem we're trying to solve that we saw is not how do I automate the surgery, but how do I amplify the surgeon to say I have the confidence as I'm operating that I have more data than what my human eyes and my history of learning can do for this patient with artificial intelligence, with technology.
00:12:25.200 --> 00:12:38.480
And then when I'm operating on that microscopic level of cutting bone to put a prosthesis in that needs to have the right fixation, the right articulation, that brings this patient back to their personalized articulation.
00:12:38.960 --> 00:12:49.279
That was the problem statement that we decided to focus on on solving rather than focusing on how do I automate a surgery to just give the surgeon some time back.
00:12:49.360 --> 00:12:58.320
Now that was also an important criteria, but that where it that's where it becomes how do you prioritize what's most important to the surgeon in their practice?
00:12:58.480 --> 00:13:01.759
And we just took a different look at that prioritization elements.
00:13:02.080 --> 00:13:15.039
We said we want to be transformative to every surgeon's hands to say, we'll give you more information and more depth very quickly, very fast, you know, without you having to like go into a cerebral thinking mode.
00:13:15.120 --> 00:13:19.679
The robot will amplify your skills in your hands, still your hands doing the surgery.
00:13:19.840 --> 00:13:23.120
So we took that decision of going smaller rather than larger.
00:13:23.279 --> 00:13:32.080
And we took the decision of taking the robot and making it in your background that really gives you the information that transforms your surgical practice.
00:13:32.320 --> 00:13:44.399
And those were um pretty unique because the entire market space was moving towards large console, arm-based robots that gives you it in a way it a little bit takes away control.
00:13:44.720 --> 00:13:55.600
And um we have uh you know more than half of our surgeries that Smith and F does in certain markets being done with the robot in a way, you know, in high volume markets.
00:13:55.679 --> 00:14:01.440
And we can see the transformative change it has been able to bring to the surgeon's hands and the patient's outcomes.
00:14:01.679 --> 00:14:09.120
So that's uh that's how we took those different decisions by really going into the ethos of what problem are we trying to solve.
00:14:09.440 --> 00:14:10.240
Right, right.
00:14:10.720 --> 00:14:23.279
And and and Ridd, I mean, one of the design features of your Corey, you know, handheld robot is the real-time depth cutoff that disengages the cutting tool before it goes too deep.
00:14:23.519 --> 00:14:34.000
From an engineering standpoint, tell us a little bit about the design principles that allowed you to get there and what was the hardest kind of edge cases to d design around that.
00:14:34.320 --> 00:14:58.480
Yeah, um, I think that's a really good question because um what we uh did with this design, um, you know, which was the genesis of our of our technology, is um the idea was that, you know, as you have tools in your hands, you know, that is cutting bone or removing material from bones, I think all the industries were looking at what is the technology that can, as the surgeon is cutting, stop.
00:14:58.799 --> 00:15:15.840
Most technologies brought in, you know, those arm-based solutions to say, even if the surgeon pushes hard, this arm has enough force to push you back and stop you from the force that you're implementing to move uh to not move beyond a plane and be in a safe boundary condition.
00:15:16.000 --> 00:15:25.120
We actually thought about miniaturizing that and putting that entire
mechanism of when to stop, how to stop in a three-dimensional spatial frame.
00:15:25.279 --> 00:15:30.000
While your hand moves, the tool is independently moving on top of your hand.
00:15:30.159 --> 00:15:40.639
So what it does is when you reach a certain depth that you don't want to perforate beyond, even if your hand moves, the tool just pulls back beyond a safe guard.
00:15:41.120 --> 00:15:50.720
Almost um in as an example, I would say imagine in a two-dimensional plane, you're writing on a piece of paper and you have a big pen that you can like click on to write.
00:15:51.039 --> 00:15:58.960
Yeah, and as a as a surgeon who've used this, I I mean I couldn't agree more that it does give you that extra level of of that safety ness.
00:15:59.279 --> 00:16:08.879
So Ridd, let's let's work on this sort of the more broader theme as you you know, as a as a decision maker from a product uh product management standpoint.
00:16:09.120 --> 00:16:15.360
How do you sequence a robotic platform's roadmap, partial knees and then total knees, and then hip and even shoulders?
00:16:15.440 --> 00:16:20.080
I think that you've you've now been um if correct me if I'm wrong, FDA approved.
00:16:20.240 --> 00:16:22.720
What determines what gets built next?
00:16:22.960 --> 00:16:26.639
Is it the clinical demand, the technical readiness, or the competitive pressure?
00:16:27.039 --> 00:16:28.720
Yeah, that's a really good question, Dr.
00:16:28.879 --> 00:16:29.600
Al-Rasheed.
00:16:29.759 --> 00:16:35.919
Um and this is where I'll transform to a little bit more of my commercial hat as to how these decisions uh generally get made.
00:16:36.159 --> 00:16:38.159
But it's always a balancing act, uh, Dr.
00:16:38.320 --> 00:16:39.039
Al-Rishit.
00:16:39.120 --> 00:16:43.679
You know, we we start by saying what clinical problem are we trying to solve for?
00:16:44.000 --> 00:16:51.360
When we look at the knee space, um, you know, um in knees, you can bifurcate knees into partial knees and total knees.
00:16:51.519 --> 00:16:59.519
And partial knees is technically more demanding because you're keeping all the soft tissues of that patient that drives the motion of that patient.
00:16:59.679 --> 00:17:20.079
And knees is actually a beautifully complex biomechanical uh motion uh architecture where you have the medial side of a knee that pivots, the lateral side that rolls back, you have a patella that tracks very specifically, and the tensions on the medial and lateral sides of the knee really drive that motion.
00:17:20.240 --> 00:17:32.960
But it's not the same for every single patient because some patients walk bow-legged or virus, you know, or or some patients come in virus, and there are nuances of how their ligaments behave and their bones behave.
00:17:33.200 --> 00:17:48.960
Getting that data in and helping surgeons make that decision with AI tools and smart tools and quantifying soft tissue throughout the range of motion helped us make the decision that the first
piece where we can make an impact was in the knee space.
00:17:49.119 --> 00:18:00.720
So we started our journey with partial knees, where we proved out that, you know, there's clinical benefits, there is reduction of revision rates that you could achieve and accomplish with robotics in your hands.
00:18:00.880 --> 00:18:10.319
And we did multi-centric studies, you know, with with multitudes of years of data that's published in the world that shows the benefits of robotics, you know, in the partial knee space.
00:18:10.640 --> 00:18:21.680
And that's but that space was uh about 10 to 15%, sometimes 20% of a surgical practice, depending on which market um you're you're looking at.
00:18:21.839 --> 00:18:26.720
But we realized that that same intent can scale to a total knee surgery.
00:18:26.960 --> 00:18:30.000
Because in total knees, personalization is important.
00:18:30.160 --> 00:18:43.200
And I also think that as we took this journey over the past, you know, five, seven years bringing robotics into the world of knees, it opened up new spectrums of thinking of how a knee should be thought about.
00:18:43.359 --> 00:18:52.160
Today we have surgeons discussing on panels and podiums about the different um CPAC classifications.
00:18:52.319 --> 00:19:14.640
Because now you can measure every single patient on as we think about the next generations of iteration, we actually decided to complete our shoulder application with our handheld robotic system first, while we had our roadmap of shoulders, hips, and even other applications such as traumas and extremities that we believe robotics can really add value in the space.
00:19:14.799 --> 00:19:23.039
And in that, in that journey, we're also looking at HTO operations and ETO operations and revision operations that can be done with robotics.
00:19:23.200 --> 00:19:34.480
In the shoulder space, we see that the tools and technologies of manual surgery today, while good, can really benefit, especially in a shoulder arthroplasty when you're doing uh a shoulder operation.
00:19:34.640 --> 00:19:42.799
There's so much activities that is tied to a shoulder operation that you want to rebuild back for that patient after a shoulder is implemented.
00:19:42.960 --> 00:19:46.960
And in that space, you have uh reverse shoulders, anatomic shoulders.
00:19:47.200 --> 00:19:48.880
And as you you would appreciate, Dr.
00:19:49.039 --> 00:19:56.640
Al-Rashid, just like partial knees, anatomic shoulders requires a technical precision to make sure it fits right.
00:19:56.799 --> 00:20:03.920
And the clinical data shows us that there is opportunities for us to make that even better than where our world is today.
00:20:04.079 --> 00:20:12.559
So we took the same playbook by looking at the benefits we brought in the partial knee space and aiming for the clinical problem that we can solve.
00:20:12.720 --> 00:20:31.519
We believe that this is a space that robotics can really shine and help that market space grow, giving confidence and control to surgeons to feel comfortable doing a shoulder procedure and feel confident that in a year, two years, five years, this patient will continue performing really, really well.
00:20:31.759 --> 00:20:33.680
So that's the first direction we took.
00:20:33.839 --> 00:20:38.319
And then when I think about another indication, like hips, for example.
00:20:38.480 --> 00:20:43.839
Now, in hip surgery, it's a very interesting uh space because most hip patients do really well.
00:20:44.000 --> 00:20:50.400
Once you do a hip surgery, I mean it's one of the best elective arthroplastic procedures that anyone can do.
00:20:50.559 --> 00:20:59.119
There's been so much evolution in acetabular solutions, stem designs, the evolution of stem designs that can fit into a patient.
00:20:59.359 --> 00:21:08.880
That um when we think about it, like are we solving for even better clinical results, or are we solving for some other level of optimization?
00:21:09.039 --> 00:21:18.720
Because when we think about hips, the number one problem we see beyond infection that a robot can't particularly control is the elements of dislocation.
00:21:18.960 --> 00:21:24.160
And dislocation is a factor of, you know, how is my hip going to articulate?
00:21:24.400 --> 00:21:25.680
Where may I impinge?
00:21:26.000 --> 00:21:35.039
If depending on the inclination version of the cup that I'm putting in, the depth of the neck cut that I'm going to cut the neck at, and what offset am I setting?
00:21:35.200 --> 00:21:59.759
So the center of rotation that we try to get back in a hip, if that's optimized for that patient, and we know the activities that that patient can do, and minimizing that risk of dislocation can really actually give further confidence to a surgeon, especially in a world where, you know, now when we overlay that data of what a patient's activities can be and simulate those activities of daily living to say we can get this back.
00:22:00.480 --> 00:22:05.920
With precision, with robotics, I think that becomes the next paradigm in the hip replacement space.
00:22:06.160 --> 00:22:14.880
And when we think about it, the problem we are aiming to solve is can we make hip surgery more efficient, bring more confidence, and make it more personalized in that space?
00:22:15.039 --> 00:22:18.720
So the decisions we make are based on the value.
00:22:19.119 --> 00:22:19.440
Right.
00:22:19.599 --> 00:22:19.920
Right.
00:22:20.079 --> 00:22:20.480
Right.
00:22:20.640 --> 00:22:21.680
Thank you for sharing that.
00:22:21.920 --> 00:22:39.920
So Renit, in terms of the learning process, right, uh on the design side of, let's say, for Corey's development, was there any design assumption or dead ends that you and your team found that really was a a a big platform for you to learn and and and kind of pivot?
00:22:40.240 --> 00:22:40.559
Yeah.
00:22:40.720 --> 00:22:50.480
Um I think uh you know, through through our journey, uh there were there were many times that
we would go down a design direction and think, you know, this is the best way we can solve a problem.
00:22:50.720 --> 00:22:57.920
But um we did have many instances where we we would you know bring certain features in and we did pivot from those.
00:22:58.079 --> 00:23:00.400
I'll give an example in the knee space, right?
00:23:00.559 --> 00:23:19.279
And this is actually an interesting example because in traditional knee surgery, as you think about the manual procedure, you know, it's a step-by-step procedures that or step-by-step approach that surgeons follow, where we make a distal cut on the femur, a flat tibial cut, and then we check what the balance looks like.
00:23:19.440 --> 00:23:28.319
And then based on that balancing, we decide how much posterior bone should I take away so that in extension and inflection I can have the knee well balanced.
00:23:28.480 --> 00:23:33.440
We try to incorporate exactly that same thought process and rationale in the robotic system.
00:23:33.519 --> 00:23:40.799
And we said, you know, we just need to check extension and flexion, and that will help get a knee really balanced.
00:23:40.960 --> 00:23:49.119
But what we learned through the journey is surgeons aren't really looking for mimicking and copying the same steps if they have a robot.
00:23:49.279 --> 00:23:59.680
They're looking for additional value that the robot can provide that makes their lives easier, so important based on the decision-making data out parameters.
00:23:59.839 --> 00:24:08.880
So we pivoted to build uh even another innovative solution like the digital tensioner, where it brings consistency no matter who in the world is operating.
00:24:09.039 --> 00:24:21.200
If I'm the patient and I put a tensioner in, it will not let me overstretch or understretch the ligaments and give me the same numbers so I can make objective decisions on these patients that we are operating in with a robot.
00:24:21.599 --> 00:24:21.839
Nice.
00:24:22.079 --> 00:24:41.119
And then sort of just again, from a leadership standpoint for you know the manufacturers and engineers uh who may be you know watching, what does it take operationally to scale a surgical robotics platform from RD prototype to a reliable, regulated, mass manufactured device, which it is right now?
00:24:41.519 --> 00:24:41.920
Yeah.
00:24:42.079 --> 00:24:44.640
Um and I think that's uh a great question.
00:24:44.720 --> 00:24:49.680
You know, I think um in the world of innovation, prototypes happen much quicker, right?
00:24:49.759 --> 00:24:55.759
Because you can iterate, you can change, you know, uh dimensions, you can change software very quickly.
00:24:55.920 --> 00:24:58.240
But we are in a regulated medical device space.
00:24:58.400 --> 00:25:08.480
And I think the most important piece is how we articulate the specifications and the requirements that this robot is aiming to achieve and solve for.
00:25:08.640 --> 00:25:29.519
Um and so once we have a prototype that you know certain
say it's kind of bringing the value that I'm seeing will help me in the practice, it then we we follow uh what we call a stage gate process of saying, you know, do we have the feasibility defined that of the system, of the product that we're trying to build?
00:25:29.759 --> 00:25:33.039
And then from feasibility, it goes into actual development.
00:25:33.279 --> 00:25:44.000
Development being that while the prototype showed and proved the concept, how do we make sure that every single part and piece that we make is consistent, reliable, and within specifications?
00:25:44.240 --> 00:25:49.839
Because we don't want something to go out there in the world and perform differently than what was expected.
00:25:50.000 --> 00:26:06.880
And then comes validation to make sure through testing that when we produce these parts in thousands and thousands of volumes, that um they are within certain parametric controls, launch management that we go through as we build new products.
00:26:07.440 --> 00:26:29.359
I mean, we've seen the evolution of robotics and it's it's been exponential, and I think uh, you know, preceded with on the soft tissue side and soft tissue robotics, you know, intuitive companies and and and others with the DaVinci have in some cases arguably been game changers, right, in general surgery, urology, gynee, and other other specialties.
00:26:29.599 --> 00:26:38.240
In terms of your field dealing with hard tissue robotics, bony cuts and such, do you feel those gains are comparable to the soft tissue side?
00:26:38.480 --> 00:26:40.400
Yeah, I think it's it's a really good question.
00:26:40.559 --> 00:26:44.240
And I think um, you know, it comes back to Dr.
00:26:44.319 --> 00:26:51.680
Al-Rashid how we um uh how we internalize the value that you know technology brings to the forefront.
00:26:51.839 --> 00:27:20.000
I do believe that our journey with robotics and technology in the orthopedic space has been a little slower than when we look at the soft tissue space, because in the soft tissue space, the robotic systems completely transformed an operation, you know, and um it truly makes it uh, you know, rip not only reproducible, but changes the paradigm of the time it takes, the safety it brings um from that perspective.
00:27:20.640 --> 00:27:23.279
And ergonomics, I think also from what's yeah.
00:27:23.519 --> 00:27:33.680
If you think about navigation as a category, it started about 25-30 years ago in the space of orthopedics, but the growth that we saw of navigation was 1 to 2%.
00:27:34.319 --> 00:27:48.240
So it's not just the software or the augmentation of data, but the control of the procedure with robotics that actually scaled robotics to be 35-40% of the market, as we said today, depending on which market we look at.
00:27:48.400 --> 00:27:50.240
And I don't see that slowing down.
00:27:50.720 --> 00:28:07.920
And yes, while there are certain commercial aspects to it, commercial aspects by itself would not survive if the value,
the clinical, the efficiency, and the economic value doesn't sustain and back up, you know, the procedural shift that we are seeing towards this world.
00:28:08.079 --> 00:28:15.279
But I foresee a world in the next three to four years where more than three-quarters of surgeries would be done with robotics.
00:28:15.359 --> 00:28:19.279
We certainly see it in quite a few markets just for our own company.
00:28:19.440 --> 00:28:29.920
And uh, while that's a niche, I certainly believe that that's going to be the same when we think about the other indications such as hips and shoulders as we make that transformative journey.
00:28:30.079 --> 00:28:38.559
So I see that being slightly slower than the soft tissue space, but an inevitable future for us in this orthopedic space.
00:28:38.880 --> 00:28:46.720
Ridith, you mentioned that some of your decision making is is you know taking into consideration the clinical value proposition, right?
00:28:46.960 --> 00:28:56.640
I mean, in the knee space, you mentioned the the out the dissatisfaction rate in terms of outcomes, knee replacement, you mentioned the dislocation issue on the hip side.
00:28:56.720 --> 00:29:01.119
And so obviously, you know, your your focus is is solving clinical problems.
00:29:01.359 --> 00:29:08.160
From an engineering standpoint, what do you think the data is suggesting in terms of what is being solved?
00:29:08.400 --> 00:29:09.440
Is it alignment?
00:29:09.519 --> 00:29:10.319
Is it precision?
00:29:10.400 --> 00:29:13.039
Is it soft tissue balance or something else?
00:29:13.359 --> 00:29:14.720
Yeah, it's a great question.
00:29:14.799 --> 00:29:27.440
And uh maybe I'll also clarify that uh, you know, on the knee side, we focused on uh the solutions that we can bring for um um a clinical but more a patient-centric problem of satisfaction.
00:29:27.680 --> 00:29:39.599
But along with that, the you know, secondary, tertiary benefits that we unlocked, I'll give an example of you know, we were the first system cleared by the FDA to do revision knee surgeries with our robotic system.
00:29:39.920 --> 00:29:51.039
Very recently we published a NASA TLX study to look at the you know, the um mental burden of doing a revision surgery and the speed and economics of doing a revision surgery.
00:29:51.359 --> 00:30:02.880
Revision surgeries, for example, require a lot of instruments because you need the backup, because it's truly an art form of when you take an old implant out, what's remaining, figuring out soft tissue balancing.
00:30:03.039 --> 00:30:20.160
And we actually showed uh some significant results in that space of you know lower um emotional burdens while doing revision surgery, lower cost to serve when you're doing a revision surgery, and lower time, you know, making revision surgery more standardized and consistent.
00:30:20.400 --> 00:30:25.279
In the partial knee space, we demonstrated faster return to sport for patients.
00:30:25.440 --> 00:30:26.880
So different benefits, right?
00:30:27.039 --> 00:30:38.720
A benefit in the revision surgery where not only were patients recovering faster, every implant that you're going to implant into a patient is pre-packaged for you and it's delivered to you.
00:30:38.880 --> 00:30:43.599
It changes the economics of how we perform surgery in this space.
00:30:43.759 --> 00:30:51.359
And those are the different benefits that we are unlocking and we want to be able to provide in an orthopedic solution.
00:30:51.599 --> 00:31:02.559
It becomes a procedural um solution with robotics and technology rather than just the clinical benefits, which is uh um critical and important.
00:31:02.720 --> 00:31:08.960
There has to be some solution that we're bringing in, but what's the secondary and tertiary benefits that transforms practice?
00:31:09.359 --> 00:31:10.960
For robotics that actually holds up.
00:31:11.279 --> 00:31:13.200
Yeah, I think uh it's it's a great question.
00:31:13.359 --> 00:31:22.640
You know, I think there are different modalities through which you know uh we in this world of um medtech provide these cares, right?
00:31:22.720 --> 00:31:32.960
So we have hospital systems, we have ambulatory surgical systems, we have inpatient-outpatient care, and the economics in in all these centers are going to be slightly different.
00:31:33.680 --> 00:31:45.519
And as we think about, so if I just focus on one and take ambulatory surgical centers as an example, uh ASEs need to be run in a lean and operationally efficient fashion.
00:31:45.680 --> 00:31:50.799
And when we think about surgeries, surgeries in orthopedic space is asset heavy.
00:31:51.039 --> 00:32:04.799
And when we think about the value that technology can bring, as we talk to surgeons and talk about the clinical benefits, it is equally important for us to be able to explain the economic benefits to stay more than 6 p.m.
00:32:05.039 --> 00:32:07.200
on a Saturday to do that surgery.
00:32:07.279 --> 00:32:11.519
But I know that this is the time it takes, then everything can be planned differently.
00:32:11.599 --> 00:32:14.480
And that changes economics in settings of that nature.
00:32:14.720 --> 00:32:24.319
So we have uh quite a few health economic studies that we have performed in the space that demonstrate those differences, but um, it also needs to get individualized.
00:32:24.480 --> 00:32:37.200
And that's where when we think about data coming out of robotic systems, we're actually looking at the connections of data from the hospital system, two elements of power systems from your uh theater, that changes the economics.
00:32:37.359 --> 00:32:40.160
You're not sterilizing batteries, that changes economics.
00:32:40.319 --> 00:32:49.359
So that's where I think um robotics actually has a lot more economical advantages it can bring in, you know, beyond the initial investment.
00:32:49.519 --> 00:32:54.160
Just like we invest in a bed and then the then it reaps the benefits.
00:32:54.319 -->
00:33:00.480
And it's going to be a very similar um story that we've actually seen happen in the space.
00:33:00.880 --> 00:33:09.039
And and and what's your what are you seeing in terms of the how the adoption curve looks like from a commercial standpoint?
00:33:09.200 --> 00:33:19.920
From you know, how long is it taking typical hospital systems to go from evaluation to full utilization and what are factors that accelerate that process or what stalls it?
00:33:20.240 --> 00:33:22.319
Yeah, no, it uh again, a great question, Dr.
00:33:22.400 --> 00:33:23.200
Al-Rashid.
00:33:23.279 --> 00:33:33.279
I think um when we look at the this piece, I think um uh it really depends on, you know, what is the decision-making process for a hospital or an ambulatory surgical center.
00:33:33.440 --> 00:33:39.920
Um, I think the critical pieces are does the surgeon who's going to use it believe that this is beneficial for their practice?
00:33:40.160 --> 00:33:45.519
The second piece is does the math work out, you know, to bring that system into their practice?
00:33:45.759 --> 00:33:53.519
It's usually those two pieces, if answered really quickly and really well for that individualized practice setting.
00:33:53.680 --> 00:34:14.880
Um, we see actually pretty quick adoption from awareness to real life experiences, real life experiences in hands of surgeons like you, surgeons across the world, who can talk to their peers and say, you know, this has actually transformed my practice beyond just um the industry coming to you and saying this is going to be something new and different.
00:34:15.039 --> 00:34:48.320
Um so in my journey, what what I uh think um, you know, that I can share is when we innovate something brand new, you know, it's really important to think about uh the early adopters, the transformative um uh transformative customers who believe that the world can change, you know, and starting with those customers who can become advocates because they believe they see the results in their hands, that really helps in the adoption uh curvature of what we see out there in the world.
00:34:48.480 --> 00:34:49.920
So today we benefit from that.
00:34:50.079 --> 00:34:58.639
And that's why we see that um utilization and penetration of robotics kind of skyrocketing, but I truly believe that that is going to become the future.
00:34:59.039 --> 00:35:09.519
So just just kind of on that point, you know, there's some estimates suggest that the robotic market has been growing year and year between 27 to 37 percent.
00:35:10.239 --> 00:35:13.599
Um what's what do you think is I mean, you mentioned a few points.
00:35:13.760 --> 00:35:16.559
What do you think are the key factors driving that growth?
00:35:16.719 --> 00:35:22.000
Do you do you see that trend to continue, or are you expecting to that to plateau?
00:35:22.320 --> 00:35:33.840
Yeah, I um I think um perhaps uh the way I would say it is the robotic penetration has been growing at that rate, like you mentioned, between 25, 35, in some markets even more.
00:35:34.079 --> 00:35:37.280
But it's it's penetrating in certain indications and procedures.
00:35:37.440 --> 00:35:44.400
If you break down orthopedics into knee, hip, shoulder, I think knees is where we've seen that growth rate really take off.
00:35:44.559 --> 00:35:54.800
But in hips and shoulder, I think there's a world of opportunity, uh, you know, where I would say, you know, a lot of procedures are still done with manual techniques uh from that perspective.
00:35:54.960 --> 00:36:04.800
So I do see over the next five, ten years uh that growth rate continuing, you know, because today it, you know, where where robotics started was one robot for one hospital.
00:36:04.960 --> 00:36:13.440
But I see a future where robotics is one robot in every OR so that you can do any procedure with that uh technology, with that scale.
00:36:13.679 --> 00:36:22.719
Um so I believe that that growth rate will actually continue for a while before it standardizes um in in orthopedic settings.
00:36:23.119 --> 00:36:23.519
Right.
00:36:24.000 --> 00:36:30.079
There are obviously new technologies coming into the market, and maybe some are um synergistic.
00:36:30.320 --> 00:36:37.760
For example, AI, you know, there's a lot of talk about AI systems and performing cognitive functions, right?
00:36:37.840 --> 00:36:43.199
Which which um a surgeon performs with the current robotic technology.
00:36:43.519 --> 00:36:55.280
AI systems that are coming into the market augment visualizations, you know, virtual reality, mixed reality, you know, uh sort of um platforms.
00:36:55.519 --> 00:37:00.960
And there is also talk about autonomous uh robotic platforms.
00:37:01.039 --> 00:37:03.599
Uh what where do you see this trend going?
00:37:03.840 --> 00:37:04.239
Yeah.
00:37:04.400 --> 00:37:06.480
Uh you know, when I think about robotics, Dr.
00:37:06.639 --> 00:37:24.159
Al-Rasheed, I see that artificial intelligence, augmented reality are fundamentally the subset tools that complement robotics and will become a part of these ecosystems as they percolate and penetrate uh in this space.
00:37:25.039 --> 00:37:52.400
I think that when we think about an entire procedural solution and how a surgeon is operating in a procedure, these software choices or hardware choices become personalized choices of surgeons to say I am still the surgeon in control with technology that keeps me safe and helps me personalize the cuts I make while giving me the augmentation of information that I believe is truly transformative for my practice.
00:37:52.719 --> 00:38:14.320
But it makes my surgery standardized to X amount of minutes, and it makes sure that my operation is economically sound and reduces the cost to serve to a certain level without any compromise, but also with a potential benefit to the patient's satisfaction and the patient outcomes that I deliver through my hands.
00:38:14.480 --> 00:38:38.800
So when I think about AI, we
have already incorporated artificial intelligence in our balancing algorithms, in our personalized planning algorithms, and we see a transformation and evolution continue to happen in this disruptive artificial intelligence space, you know, where someday you could be talking to the Corey and saying, hey, Corey, plan my hip this way, and it would do it for you.
00:38:38.880 --> 00:38:41.760
Um, or plan my knee this way, and do it for you.
00:38:41.920 --> 00:38:44.320
So we see that scale across indications.
00:38:44.480 --> 00:39:01.119
And with regards to um augmentation of information in your eyes, I mean, we are seeing um such values that that continue to evolve in the space that you could be seeing overlays of of what you're cutting on the bone rather than looking at a screen.
00:39:01.280 --> 00:39:06.000
And we certainly envision a future that could bring that to reality.
00:39:06.159 --> 00:39:08.719
But the autonomous piece is an interesting one, right?
00:39:08.800 --> 00:39:10.159
Uh when we think about it.
00:39:10.400 --> 00:39:19.599
And um I think that where we stand today, and I could be corrected in three years, four years as we take this journey together in this space.
00:39:19.840 --> 00:39:29.440
But today, as we humans come to get care from the hands of surgeons, we do we do rely a lot on that human connection.
00:39:29.679 --> 00:39:39.039
And that connection of saying that the surgeon is going to be there, you know, personally taking care of me, means the world, you know, at at this point for patients.
00:39:39.280 --> 00:39:57.599
So I think um from that perspective, our our direction and our journey, the way I look at the value that we bring is really amplifying the surgeon's skills, is really bringing control and confidence into the surgeon's hands so that the patients know a hand to shake and say, thank you, you know, for for taking care of me.
00:39:57.760 --> 00:40:08.719
Uh I think technology really needs to evolve to like get those sensory fields to a level that uh that takes that untangible skill to meet that autonomous.
00:40:08.880 --> 00:40:12.320
Because it's not just the cuts, it's the entire field of a surgery.
00:40:12.480 --> 00:40:15.440
So we think uh is there a future that could come along?
00:40:15.679 --> 00:40:16.239
Perhaps.
00:40:16.400 --> 00:40:28.400
I just think it's not immediate until all of these elements combine together to build an autonomous robot that we can augment that feel and that art of a surgeon's practice.
00:40:28.719 --> 00:40:28.880
Right.
00:40:29.039 --> 00:40:54.000
And I think when I speak to surgeons who are pioneering on the soft tissue side of things, they they say, you know, those same things that I think where there there has to be incremental improvements both in visualization but also perception, and for that perception to translate into being able to discern between um different tissues and consistencies before we can even get to that level.
00:40:54.320 --> 00:40:59.760
So where do you think Ridith is the next competitive edge in this space?
00:40:59.920 --> 00:41:01.119
Is it still hardware?
00:41:01.280 --> 00:41:05.519
Is it shifting to software, or is it now more data and predictive planning?
00:41:05.840 --> 00:41:10.079
Yeah, I think um if I simplify those pieces to the value, uh Dr.
00:41:10.239 --> 00:41:14.239
Al-Rashid, I think it really is simplicity.
00:41:14.400 --> 00:41:18.559
It's efficiency and simplicity bringing that into an operating theater.
00:41:18.880 --> 00:41:42.400
And to deliver that, there can be focused efforts on software and artificial intelligence, you know, in your practice that makes the surgery faster, easier, more efficient, you know, that takes maybe something that takes four steps or five steps to do, or six incremental things that you did with a cut and a test and a cut and a test, but it's singular in execution.
00:41:42.559 --> 00:41:51.039
I think that's the paradigm shifts that uh will change this practice even even further, you know, with technology.
00:41:51.360 --> 00:41:52.159
Right, right.
00:41:52.639 --> 00:41:56.639
So um in terms of there's always trade-offs, right?
00:41:56.719 --> 00:42:03.920
When you're doing when you're designing things, you have different uh goals, and you you you alluded to quite a few of them.
00:42:04.480 --> 00:42:14.400
How do you how do you navigate the trade-offs between what's technically plausible, what's commercially viable, and uh what a hospital will actually pay for?
00:42:14.719 --> 00:42:15.199
Yeah.
00:42:15.440 --> 00:42:29.119
Um and I think uh in that aspect, I think you know, uh just the examples of um there there are certain things that are you know technically possible as as an example.
00:42:29.199 --> 00:42:34.000
Uh I'll I'll say, like for example, autonomous arms, you know, they're technically very possible.
00:42:34.079 --> 00:42:36.960
And in fact, there are companies who are doing that at this point in time.
00:42:37.119 --> 00:43:00.480
You know, but so Riddha, as a as a leader uh in the you know, the biomedical engineering and the medtech sales, that that intersection, for those people who you know are starting off or working in this space, what do you what would you say is a an underrated skill that made the biggest difference in your own trajectory, you know, in developing sort of these pioneering design models?
00:43:00.800 --> 00:43:16.800
Yeah, um I think Total Rashid, you know, in this space, one is the ability to um continue learning and continue transforming the skills uh that we start off with in our career.
00:43:17.119 --> 00:43:35.679
Because, you know, in the last 10, 15 years that I've been in this space, there's not a stoppage of learning that I've had, you know, to really see how the world is transforming and how the world is adapting to new methodologies, to new techniques, to new design processes.
00:43:36.079 --> 00:43:40.239
And that is hypercritical because the world is not
constant.
00:43:40.480 --> 00:44:19.360
And the ability to understand the deeper needs of what we are trying to solve for, you know, beyond going beyond the current understanding of this is what I'm solving for now, to this is what truly the solution needs to be to bring value, I think is the biggest trend that I've seen, you know, in my team members, you know, ones that I've seen uh myself gravitate towards is challenge the assumptions where I feel that I'm right, you know, and see what if I'm wrong and what happens then, and having the iterative mindset to say, when I built this, it's not done.
00:44:19.599 --> 00:44:24.559
But it's a constant evolution of what I built and how do I continuously keep improving on that?
00:44:24.800 --> 00:44:30.000
I think that's what makes um makes a difference, you know, from that perspective.
00:44:30.480 --> 00:44:30.719
Right.
00:44:30.960 --> 00:44:31.599
Great point.
00:44:31.920 --> 00:44:39.840
So what what would you say if somebody asked you rather what do you want Corey's legacy to be in the next 10 to 20 years?
00:44:40.239 --> 00:44:43.119
Yeah, I think um um that's a great question.
00:44:43.360 --> 00:44:57.199
I do see that in the next 10, 15, 20 years, that Corey came in at a point in time where orthopedics had just started um embracing the concepts of robotics um in the space.
00:44:57.440 --> 00:45:11.519
I think that in 20 years it will be looked back upon as the system that started this journey of bringing technology into the space and uh becomes foundationally the standard of care of how orthopedics is done.
00:45:11.679 --> 00:45:33.199
And I think that'll be something that you know we all together can be proud of, you know, because just like me, you've been a part of that journey, you know, of robotics and technology and this space of transforming healthcare and transforming orthopedics to bring it to a new generation uh going beyond um just the manual instruments that we had previously.
00:45:33.599 --> 00:45:34.320
Thank you, Reddit.
00:45:34.400 --> 00:45:38.079
That's very, very, you know, illuminating words of wisdom.
00:45:38.320 --> 00:45:40.559
So we're almost coming to a close.
00:45:40.719 --> 00:45:41.920
So we have a few more.
00:45:42.079 --> 00:45:47.199
I'll ask you, I won't take too much more of your time, but uh what we call uh a rapid fire round.
00:45:47.280 --> 00:45:55.119
So we'll ask you some quick, poignant questions and uh we'll uh we'll try and get a quick, fast response um to those questions.
00:45:55.280 --> 00:45:56.000
So you ready?
00:45:56.239 --> 00:45:56.960
Yeah, I'm ready.
00:45:57.280 --> 00:46:03.440
Okay, so one technology outside of orthopedics that you're looking at for creative ideas?
00:46:03.760 --> 00:46:10.639
Um I would say artificial intelligence, you know, whether it's imaging or uh fast decision making.
00:46:10.960 --> 00:46:11.199
Okay.
00:46:11.599 --> 00:46:14.639
One myth about surgical robots you wish would die.
00:46:14.960 --> 00:46:15.679
To adopt.
00:46:16.079 --> 00:46:19.920
Uh one word patients should know before they ask for robotic surgery.
00:46:20.159 --> 00:46:21.679
Uh one word that patients should know.
00:46:21.760 --> 00:46:23.039
Um it's personalized.
00:46:23.280 --> 00:46:24.239
It's built for you.
00:46:24.480 --> 00:46:25.280
It was a pleasure, Dr.
00:46:25.440 --> 00:46:26.079
Al-Rashid.
00:46:26.239 --> 00:46:28.480
Thank you so much for giving me this opportunity.
00:46:28.639 --> 00:46:29.360
So thank you.
00:46:29.840 --> 00:46:32.559
Thank you for joining us on Beyond the Scalpel.
00:46:32.719 --> 00:46:38.719
We hope today's conversation gave you new insights into the future of health, healing, and human performance.
00:46:38.960 --> 00:46:46.800
If you enjoyed this episode, be sure to subscribe and share it with others passionate about medicine, wellness, and innovation.
00:46:47.039 --> 00:46:48.000
To learn more about Dr.
00:46:48.159 --> 00:46:55.840
Mammon al Rashid, visit www.palmbeachregenerativeorthopedic.com.
00:46:56.000 --> 00:47:03.199
Until next time, stay curious, stay informed, and take care of your health, both inside and beyond the scalpel.